Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNon-cash ItemsShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Short-Term Debt issuances (2020 - 2022)

Historic Short-Term Debt issuances for Roivant Sciences (ROIV) over the last 3 years, with Q4 2022 value amounting to $159.9 million.

  • Roivant Sciences' Short-Term Debt issuances rose 33928.3% to $159.9 million in Q4 2022 from the same period last year, while for Dec 2023 it was $159.9 million, marking a year-over-year decrease of 5510.95%. This contributed to the annual value of $159.9 million for FY2023, which is 33928.3% up from last year.
  • According to the latest figures from Q4 2022, Roivant Sciences' Short-Term Debt issuances is $159.9 million, which was up 33928.3% from $159.9 million recorded in Q2 2022.
  • In the past 5 years, Roivant Sciences' Short-Term Debt issuances registered a high of $159.9 million during Q2 2022, and its lowest value of -$36.4 million during Q4 2020.
  • Its 3-year average for Short-Term Debt issuances is $71.2 million, with a median of $36.4 million in 2021.
  • In the last 5 years, Roivant Sciences' Short-Term Debt issuances soared by 20000.0% in 2021 and then skyrocketed by 33928.3% in 2022.
  • Roivant Sciences' Short-Term Debt issuances (Quarter) stood at -$36.4 million in 2020, then surged by 200.0% to $36.4 million in 2021, then soared by 339.28% to $159.9 million in 2022.
  • Its Short-Term Debt issuances was $159.9 million in Q4 2022, compared to $159.9 million in Q2 2022 and $36.4 million in Q4 2021.